MIRAPEXIN Side Effects

5809181-6 | Hallucination, Paraesthesia
on Jul 04, 2008 Male patient from , 47 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Mirapexin (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, paraesthesia. Mirapexin dosage: . During the same period patient was treated with REQUIP (View Requip Review and Requip Label ), LEVODOPA (View Levodopa Review and Levodopa Label ).

5805036-1 | Upper Gastrointestinal Haemorrhage
Patient was taking Mirapexin (View Usage). Patient had the following side effects: upper gastrointestinal haemorrhage on Jul 04, 2008 from Additional patient health information: Male patient , 79 years of age, . Mirapexin dosage: 1,59 Mg (0,18 Mg And 0,7 Mg Strength). During the same period patient was treated with EXELON (View Exelon Review and Exelon Label ), MADOPAR RETARD (View Madopar Retard Review and Madopar Retard Label ), SINEMET (Levodopa 25+carbidopa 100) (View Sinemet Review and Sinemet Label ), STALEVO 100 (50mg/12,5 Mg/200 Mg) (View Stalevo 100 Review and Stalevo 100 Label ).

5788114-5 | Constipation, Hepatic Encephalopathy
Adverse event was reported on Jun 20, 2008 by a Male patient taking Mirapexin (View Usage) (Dosage: ) was diagnosed with hepatic cirrhosis and. Location: , 51 years of age, After Mirapexin was administered, patient had the following side effects: constipation (What is constipation?), hepatic encephalopathy. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DACORTIN (View Dacortin Review and Dacortin Label ), URSOBILANE (View Ursobilane Review and Ursobilane Label ).

5754417-3 | Confusional State, Dysarthria, Hemiparesis
on May 22, 2008 Male patient from , 78 years of age, was diagnosed with restless legs syndrome and was treated with Mirapexin (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, dysarthria, hemiparesis. Mirapexin dosage: .


5716897-9 | Confusional State, Somnolence
on Apr 22, 2008 Female patient from , 85 years of age, was diagnosed with restless legs syndrome and was treated with Mirapexin (View Usage). Patient had the following side effects: confusional state, somnolence. Mirapexin dosage: . Patient was hospitalized.

5533713-9 | Coordination Abnormal, Hallucination, Speech Disorder, Vascular Encephalopathy
Patient was taking Mirapexin (View Usage). After Mirapexin was administered, patient had the following side effects: coordination abnormal, hallucination, speech disorder, vascular encephalopathy on Nov 30, 2007 from Additional patient health information: Female patient , 76 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), vascular encephalopathy, diabetes mellitus, depression (What is depression?), constipation (What is constipation?) and. Mirapexin dosage: . During the same period patient was treated with SOMAZINA (View Somazina Review and Somazina Label ), INSULATARD FLEXPEN (View Insulatard Flexpen Review and Insulatard Flexpen Label ), NOBRITOL (View Nobritol Review and Nobritol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PLANTABEN (View Plantaben Review and Plantaben Label ).

5512100-3 | Blood Glucose Increased
Adverse event was reported on Nov 06, 2007 by a Female patient taking Mirapexin (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?), hypertension, type 1 diabetes mellitus and. Location: , 73 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased. During the same period patient was treated with ACE INHIBITOR (View Ace Inhibitor Review and Ace Inhibitor Label ), INSULIN (View Insulin Review and Insulin Label ).

5339159-0 | Road Traffic Accident, Sudden Onset Of Sleep
on May 28, 2007 Male patient from ITALY , weighting 238.1 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), atrial fibrillation (What is atrial fibrillation?), hypertension and was treated with Mirapexin (View Usage). Patient had the following side effects: road traffic accident, sudden onset of sleep. Mirapexin dosage: . During the same period patient was treated with AMIODAR (View Amiodar Review and Amiodar Label ), CARDIRENE (View Cardirene Review and Cardirene Label ), VASERETIC (View Vaseretic Review and Vaseretic Label ), CARDURA (View Cardura Review and Cardura Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), MADOPAR (View Madopar Review and Madopar Label ).

5301110-7 | Road Traffic Accident, Sudden Onset Of Sleep
on Apr 12, 2007 Female patient from ITALY , weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), hiatus hernia, migraine (What is migraine?) and was treated with Mirapexin (View Usage). After Mirapexin was administered, patient had the following side effects: road traffic accident, sudden onset of sleep. Mirapexin dosage: . During the same period patient was treated with LEVODOPA BENSERAZIDE (View Levodopa-benserazide Review and Levodopa-benserazide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FROVATRIPTAN (View Frovatriptan Review and Frovatriptan Label ).

5114249-6 | Hyponatraemia, Somnolence
Patient was taking Mirapexin (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, somnolence on Sep 18, 2006 from Additional patient health information: Female patient , 78 years of age, was diagnosed with extrapyramidal disorder, essential hypertension, cardiac failure and. Mirapexin dosage: . During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), COROPRES (View Coropres Review and Coropres Label ), SEGURIL (View Seguril Review and Seguril Label ). Patient was hospitalized.

5076039-2 | Nausea
Adverse event was reported on Jul 12, 2006 by a Female patient taking Mirapexin (View Usage) (Dosage: ) was diagnosed with extrapyramidal disorder, tremor and. Location: , 66 years of age, Patient had the following side effects: nausea (What is nausea?). During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ).

5049699-X | Eye Abscess, Ocular Hyperaemia
on May 31, 2006 Male patient from , weighting 200.6 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), anxiety (What is anxiety?), hypertension and was treated with Mirapexin (View Usage). After Mirapexin was administered, patient had the following side effects: eye abscess, ocular hyperaemia. Mirapexin dosage: . During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), LOGIMAT (View Logimat Review and Logimat Label ). Patient was hospitalized.

5049693-9 | Anxiety, Delusion, Hallucination
on Feb 28, 2006 Female patient from , weighting 130.1 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Mirapexin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), delusion, hallucination. Mirapexin dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), SELOZOK (View Selozok Review and Selozok Label ), CORUNO (View Coruno Review and Coruno Label ). Patient was hospitalized.

4896175-0 | Neuroleptic Malignant Syndrome, Platelet Count Decreased, Transaminases Increased
Patient was taking Mirapexin (View Usage). Patient had the following side effects: neuroleptic malignant syndrome, platelet count decreased, transaminases increased on Jan 19, 2006 from Additional patient health information: Female patient , 71 years of age, was diagnosed with progressive supranuclear palsy (What is progressive supranuclear palsy?), diabetes mellitus insulin-dependent and. Mirapexin dosage: . During the same period patient was treated with AKINETON (View Akineton Review and Akineton Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.